These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32220488)

  • 21. Ranolazine for improving coronary microvascular function in patients with nonobstructive coronary artery disease: a systematic review and meta-analysis with a trial sequential analysis of randomized controlled trials.
    Ling H; Fu S; Xu M; Wang B; Li B; Li Y; Liu X; Zhang X; Wang Q; Li A; Liu M
    Quant Imaging Med Surg; 2024 Feb; 14(2):1451-1465. PubMed ID: 38415135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranolazine and Microvascular Angina by PET in the Emergency Department: Results From a Pilot Randomized Controlled Trial.
    Safdar B; D'Onofrio G; Dziura J; Russell RR; Johnson C; Sinusas AJ
    Clin Ther; 2017 Jan; 39(1):55-63. PubMed ID: 28081848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention.
    Lu Y; Zhang H; Wang Y; Zhou T; Welsh J; Liu J; Guan W; Li J; Li X; Zheng X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    JAMA Netw Open; 2018 Dec; 1(8):e185446. PubMed ID: 30646292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial.
    Sinha A; Rahman H; Douiri A; Demir OM; De Silva K; Clapp B; Webb I; Gulati A; Pinho P; Dutta U; Ellis H; Shah AM; Chiribiri A; Marber M; Webb AJ; Perera D
    Circulation; 2024 Jan; 149(1):36-47. PubMed ID: 37905403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of Subjective Well-Being by Ranolazine in Patients with Chronic Angina and Known Myocardial Ischemia (IMWELL Study).
    Bavry AA; Park KE; Choi CY; Mahmoud AN; Wen X; Elgendy IY
    Cardiol Ther; 2017 Jun; 6(1):81-88. PubMed ID: 28044265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranolazine: impact on quality of life in patients with stable angina pectoris, results from an observational study in Austria - the ARETHA AT study.
    Zweiker R; Aichinger J; Metzler B; Lang I; Wallner E; Delle-Karth G
    Wien Klin Wochenschr; 2019 Apr; 131(7-8):165-173. PubMed ID: 30963332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranolazine versus placebo in patients with ischemic cardiomyopathy and persistent chest pain or dyspnea despite optimal medical and revascularization therapy: randomized, double-blind crossover pilot study.
    Shammas NW; Shammas GA; Keyes K; Duske S; Kelly R; Jerin M
    Ther Clin Risk Manag; 2015; 11():469-74. PubMed ID: 25848292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA).
    Ford TJ; Stanley B; Sidik N; Good R; Rocchiccioli P; McEntegart M; Watkins S; Eteiba H; Shaukat A; Lindsay M; Robertson K; Hood S; McGeoch R; McDade R; Yii E; McCartney P; Corcoran D; Collison D; Rush C; Sattar N; McConnachie A; Touyz RM; Oldroyd KG; Berry C
    JACC Cardiovasc Interv; 2020 Jan; 13(1):33-45. PubMed ID: 31709984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary endothelial function testing may improve long-term quality of life in subjects with microvascular coronary endothelial dysfunction.
    Reriani M; Flammer AJ; Duhé J; Li J; Gulati R; Rihal CS; Lennon R; Tilford JM; Prasad A; Lerman LO; Lerman A
    Open Heart; 2019; 6(1):e000870. PubMed ID: 30815267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report.
    Yuriivna Osovska N; Vitaliivna Kuzminova N
    Pol Merkur Lekarski; 2016 Dec; 41(246):287-292. PubMed ID: 28024133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial.
    Arnold SV; Kosiborod M; Li Y; Jones PG; Yue P; Belardinelli L; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):844-50. PubMed ID: 25249560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function.
    Shah NR; Cheezum MK; Veeranna V; Horgan SJ; Taqueti VR; Murthy VL; Foster C; Hainer J; Daniels KM; Rivero J; Shah AM; Stone PH; Morrow DA; Steigner ML; Dorbala S; Blankstein R; Di Carli MF
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.
    Cohen DJ; Van Hout B; Serruys PW; Mohr FW; Macaya C; den Heijer P; Vrakking MM; Wang K; Mahoney EM; Audi S; Leadley K; Dawkins KD; Kappetein AP;
    N Engl J Med; 2011 Mar; 364(11):1016-26. PubMed ID: 21410370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial.
    Birkeland K; Khandwalla RM; Kedan I; Shufelt CL; Mehta PK; Minissian MB; Wei J; Handberg EM; Thomson LE; Berman DS; Petersen JW; Anderson RD; Cook-Wiens G; Pepine CJ; Bairey Merz CN
    JMIR Res Protoc; 2017 Dec; 6(12):e255. PubMed ID: 29263019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life in patients with coronary artery disease treated for angina: validity and reliability of German translations of two specific questionnaires.
    Höfer S; Benzer W; Schüssler G; von Steinbüchel N; Oldridge NB
    Qual Life Res; 2003 Mar; 12(2):199-212. PubMed ID: 12639066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seattle Angina Pectoris Questionnaire and Canadian Cardiovascular Society Angina Categories in the Assessment of Total Coronary Atherosclerotic Burden.
    Guimarães WVN; Nicz PFG; Garcia-Garcia HM; Abizaid A; Santos LM; Rosa VE; Ribeiro MH; Mehta S; Ribeiro E; Lemos PA; Brito FS; Hajjar L; Filho RK; Campos CM
    Am J Cardiol; 2021 Aug; 152():43-48. PubMed ID: 34175106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of myocardial bridging associated with coronary endothelial dysfunction in patients with chest pain and non-obstructive coronary artery disease.
    Sara JDS; Corban MT; Prasad M; Prasad A; Gulati R; Lerman LO; Lerman A
    EuroIntervention; 2020 Feb; 15(14):1262-1268. PubMed ID: 30636680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinociceptive effect of ranolazine and trimetazidine.
    Tolunay H
    Expert Rev Cardiovasc Ther; 2021 May; 19(5):457-464. PubMed ID: 33823738
    [No Abstract]   [Full Text] [Related]  

  • 40. Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials.
    Wenger NK; Chaitman B; Vetrovec GW
    Am J Cardiol; 2007 Jan; 99(1):11-8. PubMed ID: 17196454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.